Want to see ARWR full AI Analyst Report?
Arrowhead Pharmaceuticals (ARWR) Ownership Overview
3.64% Insiders
19.68% Mutual Funds
25.11% Other Institutional Investors
24.72% ETFs
26.84% Public Companies and
Individual Investors
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 69.52% of the company’s stock is owned by Institutional Investors, 3.64% is owned by Insiders, and 26.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 20, 2026 | xxxxxxxxxxxxx | $173920 | |
Aug 20, 2026 | xxxxxxxxxxxxx | $1012680 | |
Dec 19, 2025 | xxxxxxxxxxxxx | $5443462 | |
Dec 16, 2025 | xxxxxxxxxxxxx | $12348802 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $110083820 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $78061393 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $113221873 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $28121 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,073,249 | Institution | 9.26% | 1,128,744,319 | |
| 11,761,854 | Institution | 8.33% | 1,015,518,474 | |
| 10,571,878 | Institution | 7.48% | 912,775,947 | |
| 4,098,080 | Institution | 2.90% | 353,828,227 | |
| 3,792,739 | Insider | 2.69% | 327,465,085 | |
| 3,139,902 | Institution | 2.22% | 271,099,139 | |
| 2,523,500 | Institution | 1.79% | 217,878,990 | |
| 2,296,563 | Institution | 1.63% | 198,285,249 | |
| 1,992,783 | Institution | 1.41% | 172,056,884 | |
| 1,774,594 | Institution | 1.26% | 153,218,446 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,571,878 | Institution | 7.48% | 912,775,947 | |
| 3,139,902 | Institution | 2.22% | 271,099,139 | |
| 1,774,594 | Institution | 1.26% | 153,218,446 | |
| 1,390,822 | Institution | 0.98% | 120,083,571 | |
| 1,178,525 | Institution | 0.83% | 101,753,849 | |
| 842,272 | Institution | 0.60% | 72,721,764 | |
| 789,717 | Institution | 0.56% | 68,184,166 | |
| 578,500 | Institution | 0.41% | 49,947,690 | |
| 537,580 | Institution | 0.38% | 46,414,657 | |
| 516,610 | Institution | 0.37% | 44,604,107 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,940,461 | Institution | 3.50% | 426,559,403 | |
| 4,260,142 | Institution | 3.02% | 360,621,020 | |
| 3,364,205 | Institution | 2.38% | 79,798,943 | |
| 3,068,726 | Institution | 2.17% | 250,131,856 | |
| 1,785,731 | Institution | 1.26% | 154,180,015 | |
| 1,779,805 | Institution | 1.26% | 150,660,493 | |
| 1,622,361 | Institution | 1.15% | 137,332,859 | |
| 1,497,297 | Institution | 1.06% | 129,501,218 | |
| 1,035,381 | Institution | 0.73% | 89,394,796 | |
| 998,424 | Institution | 0.71% | 86,203,928 |
FAQ
Who Owns Arrowhead Pharmaceuticals (ARWR)?
According to the latest TipRanks data, approximately 25.11% of the company's stock is held by institutional investors, 3.64% is held by insiders, and 26.84% is held by retail investors.
What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.11% of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors.
What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.84% of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors.
Who owns the most shares of Arrowhead Pharmaceuticals (ARWR)?
iShares owns the most shares of Arrowhead Pharmaceuticals (ARWR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.